Optimal management of a patient with recurrent nasopharyngeal carcinoma

Nasopharyngeal carcinoma is rare in western countries, accounting for less than 1% of all malignancies. Despite prognosis is satisfactory for newly diagnosed, non-metastatic disease, management of recurrent disease is challenging, with a survival expectancy of approximately 6 mo with the use of chemotherapy as the sole salvage treatment. We report a case of recurrent nasopharyngeal carcinoma treated with a combination of chemotherapy, radiotherapy and surgery in the context of a multidisciplinary approach. A durable complete response was achieved.

Medienart:

E-Artikel

Erscheinungsjahr:

2014

Erschienen:

2014

Enthalten in:

Zur Gesamtaufnahme - volume:2

Enthalten in:

World journal of clinical cases - 2(2014), 7 vom: 16. Juli, Seite 297-300

Sprache:

Englisch

Beteiligte Personen:

Perri, Francesco [VerfasserIn]
Dell'Oca, Italo [VerfasserIn]
Muto, Paolo [VerfasserIn]
Schiavone, Concetta [VerfasserIn]
Aversa, Corrado [VerfasserIn]
Fulciniti, Franco [VerfasserIn]
Solla, Raffaele [VerfasserIn]
Scarpati, Giuseppina Della Vittoria [VerfasserIn]
Buonerba, Carlo [VerfasserIn]
Di Lorenzo, Giuseppe [VerfasserIn]
Caponigro, Francesco [VerfasserIn]

Links:

Volltext

Themen:

Case Reports
Cetuximab
Nasopharyngeal carcinoma
Re-irradiation
Surgery of metastases
Undifferentiated

Anmerkungen:

Date Completed 17.07.2014

Date Revised 21.10.2021

published: Print

Citation Status PubMed-not-MEDLINE

doi:

10.12998/wjcc.v2.i7.297

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM240141601